Last reviewed · How we verify

NCT02878577: TBI

Monitoring the Alterations That Occur in the Brain Following Traumatic Brain Injury

Completed Last updated 4 January 2019
What this trial tests

trial testing fMRI in Traumatic Brain Injury (TBI) in 68 participants. Completed in 18 July 2018.

Timeline
21 September 2016
Primary endpoint
3 May 2018
18 July 2018

Quick facts

Lead sponsorElMindA Ltd
StatusCompleted
Study typeOBSERVATIONAL
Enrollment68
Start date21 September 2016
Primary completion3 May 2018
Estimated completion18 July 2018
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

ElMindA Ltd

Who can join

Adults 18 to 60, any sex, with Traumatic Brain Injury (TBI). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project, will combine the data collected from existing and innovative technologies: fMRI scans, mapping brain connectivity using EEG in combination with eye-tracking technology (the BNA technology developed by ELMINDA), characterizing of cortical layers using magnetic resonance (the CoLI technology developed by Tel-Aviv University), and DTI imaging (imaging of brain tracks). To do so, Sheba's Medical Center, Tel Hashomer, joined the project and is responsible for recruiting patients from the Department of Neurosurgery and Department of Rehabilitation and also is responsible for performing the needed tests.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of fMRI

Trials testing the same drug.

Other recruiting trials for Traumatic Brain Injury (TBI)

Currently open trials in the same condition.

Other ElMindA Ltd trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02878577.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing